Equity
€3.6m ▼ 3.2%
A&E paid out €750,551 in dividends. That is 119% of the 2025 profit.
A&E
Overview
Lifetime
20 annual accounts with figures on one time axis, 35 filings since 1991peak €1.1m (2020)
€781,629▼ 20.8%
lowest -€216,647 (2013)
€630,513▼ 14.4%
peak €4.1m (2018)
€3.6m▼ 3.2%
€913,688▲ 63.7%
peak 0 FTE (2023)
0 FTE
Board3 names since 2003
2 directorsHEYLEN René Joseph Jean Maria and 1 other
Documentsfilings and deeds
22-04-2026100 days before the deadline
2025abbreviated format
Gross margin from €986,977 to €781,629Dividend €750,551Debts from €558,067 to €913,688
Key points
from the 2025 annual accountsTurnover
≈ €1.2m estimated
The abbreviated format states no turnover.
Debts
€913,688 ▲ 63.7%
Debts rose by €355,621 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
4.97 was 7.68 in 2024
Short-term debts rose from €558,067 to €913,688.
Filings
35 annual accounts since 1991
Six of the last ten came late. The 2020 accounts came latest: 31 days after the end of the period.
Position in the sector
€3.6m
More equity than 93% of companies in human health. Sector median €366,650 · 3,053 companies.
Checked score
93
Excellent
Financially stronger than 45% of small companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 1,080 companies (NACE 86, small).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025highest value
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Liquidity: current ratio 4.97, cash €158,407
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €4.6m
Figures for financial year 2025 (filed on 22-04-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 77% of them on solvency, 16% on liquidity, 68% on profitability and 18% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 20,137 companies had the same profile as A&E has now. Each dot stands for 51 companies, two years later.
95.1%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
That fits the bankruptcy probability of A&E itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for A&E. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €330,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.97 (7.68 in 2024), above the usual 1.5. Short-term debt is 20% and cash 3.5% of total assets. 20% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-04-2026, 100 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
100 days early
2024
51 days early
2023
35 days early
2022
14 days early
2021
29 days late
2020
31 days late
2019
12 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 18 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 June (4 of the last 5 accounts filed within 63 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0440535396
Purpose change
“Het bij wijze van inschrijving,inbreng,fusie samenwerking,financiële tussenkomt of anderszins verwerven van…” (deed in Dutch) · General meeting of 13-04-2023 · Gazette deed
HEYLEN René holds all the shares
Director in office: HEYLEN René · Gazette deed
1 director resigning, 2 reappointments
Resignation: HEYLEN Line · Reappointments: HEYLEN René Joseph Jean Maria and HEYLEN Micheline · HEYLEN René Joseph Jean Maria holds all the shares · General meeting of 27-03-2020 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| A&E Genk | €4.6m | €0.8m | 80.0% | 0 |
| DR. VROLIX Genk | €2.9m | €0.9m | 98.7% | 0 |
| DR. ORIS ELS Hasselt | €4.7m | €0.7m | 99.7% | 0 |
| MOVENDI Hasselt | €3.6m | €0.9m | 82.5% | 0.5 |
| ARELIN Ypres | €4.4m | €1.0m | 81.0% | 0 |
| DR. DE MEESTER & DR. SERBRUYNS Sint-Niklaas | €6.1m | €0.7m | 97.1% | 0 |
| Dr. Evert Matthys MKA Ypres | €4.1m | €0.6m | 98.5% | 0.4 |
These companies have the same main activity as A&E: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.9m and €6.1m, founded between 1995 and 2004.
Official details
Source: KBO- Status
- Active since 03-04-1990Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.350.685.5283600 Genk, since 18-01-2003
- Financial year end
- 31 December
- Peppol
- Reachable since 29-12-2025
Annual accounts 2025
- €781,629▼ 20.8%
- €630,513▼ 14.4%
- €3.6m▼ 3.2%
- €4.6m▲ 5.5%
- Filing
- Filed on 22-04-2026, 100 days before the end of the filing period
Insights on A&E
A&E files the abbreviated format. That format states no turnover. The gross margin rose from €403,621 in 2006 to €781,629 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
abbreviated format, filed on 22-04-2026, 100 days before the deadline€781,629
▼ 20.8%
€758,407
▼ 21.3%
€780,313
▼ 20.8%
€652,419
▼ 13.9%
80.0%
▼ 7.1 percentage points
4.97
▼ 2.71
Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €1.2m. Estimated: probably between €1.1m and €1.6m.
Money flows
no detail for 2025Balance sheet
balance sheet total €4.6m on 31-12-2025What the company ownsHow it is paid for
in €m
in euro
Position in the sector
80.0%
Higher than 71% of 3,053 companies in 2025.
4.97
Higher than 70% of 2,997 companies in 2025.
13.8%
Higher than 49% of 3,009 companies in 2025.
A&E
Middle half of the sector
80% of the sector
Abbreviated accounts in human health (NACE 86)
Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter · Staff: bottom quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||||||||||||||||
20/58 |
4.6m | 4.3m | 4.3m | 4.0m | 3.8m | 3.6m | 3.7m | 4.3m | 3.9m | 3.3m | 2.8m | 2.7m | 2.7m | 2.4m | 2.5m | 2.5m | 2.5m | 1.8m | 1.4m | 1.3m | |
21/28 |
14,497 | 34,998 | 53,289 | 68,125 | 84,658 | 1.1m | 1.1m | 1.2m | 1.3m | 1.3m | 1.4m | 1.4m | 1.5m | 1.6m | 1.6m | 1.6m | 1.7m | 666,435 | 666,459 | 381,685 | |
22/27 |
8,921 | 29,422 | 47,713 | 68,125 | 84,658 | 1.1m | 1.1m | 1.2m | 1.3m | 1.3m | 1.4m | 1.4m | 1.5m | 1.6m | 1.6m | 1.6m | 1.7m | 666,435 | 666,459 | 381,685 | |
22 |
- | - | - | - | 0 | 1.0m | 1.1m | 1.2m | 1.2m | 1.3m | 1.3m | 1.4m | 1.4m | 1.5m | 1.5m | 1.5m | 1.5m | 525,310 | 501,459 | 359,918 | |
23 |
- | - | - | 0 | 90 | 376 | 716 | 2,466 | 4,130 | 2,777 | 3,173 | 2,083 | 3,314 | 330 | 881 | 688 | 495 | - | - | 392 | |
24 |
8,921 | 29,422 | 47,713 | 68,125 | 78,665 | 95,407 | 198 | 486 | 7,762 | 15,038 | 33,713 | 55,385 | 42,872 | 92,509 | 106,186 | 123,332 | 148,671 | 141,125 | 165,000 | 21,375 | |
25 |
- | - | - | - | 5,903 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
26 |
- | - | - | - | - | - | - | - | - | - | - | 470 | 1,139 | 2,029 | 2,918 | 1,456 | 1,340 | - | - | - | |
28 |
5,576 | 5,576 | 5,576 | - | 0 | 50 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
29/58 |
4.5m | 4.3m | 4.2m | 4.0m | 3.8m | 2.5m | 2.6m | 3.1m | 2.6m | 2.0m | 1.5m | 1.3m | 1.2m | 873,142 | 922,655 | 851,095 | 827,445 | 1.1m | 778,715 | 876,166 | |
29 |
421,838 | 251,400 | - | - | - | - | - | - | - | - | - | 250,631 | - | - | - | - | - | - | - | - | |
290 |
- | - | - | - | - | - | - | - | - | - | - | 150,631 | - | - | - | - | - | - | - | - | |
291 |
421,838 | 251,400 | - | - | - | - | - | - | - | - | - | 100,000 | - | - | - | - | - | - | - | - | |
40/41 |
3.9m | 3.7m | 3.9m | 2.4m | 3.0m | 1.9m | 2.2m | 2.4m | 2.1m | 1.5m | 283,074 | 46,581 | 17,627 | 49,300 | 71,895 | 48,651 | 39,547 | 28,878 | 21,720 | 27,696 | |
40 |
179,247 | 42,015 | 63,226 | 114,686 | 25,000 | 7,027 | 279,869 | 289,980 | 300,127 | 343,041 | 283,074 | - | - | - | - | - | - | - | - | - | |
41 |
3.7m | 3.7m | 3.8m | 2.3m | 3.0m | 1.9m | 2.0m | 2.1m | 1.8m | 1.2m | - | 46,581 | 17,627 | 49,300 | 71,895 | 48,651 | 39,547 | 28,878 | 21,720 | 27,696 | |
50/53 |
- | 0 | 100,000 | - | - | - | - | - | - | - | - | 541,345 | 641,346 | 541,345 | 526,171 | 515,435 | 501,133 | 462,248 | 448,767 | 430,060 | |
54/58 |
158,407 | 135,093 | 126,567 | 1.4m | 536,745 | 439,094 | 322,074 | 715,648 | 527,994 | 526,343 | 1.2m | 414,535 | 295,371 | 7,924 | 9,722 | 36,339 | 18,019 | 521,520 | 280,958 | 390,232 | |
490/1 |
111,068 | 163,087 | 146,203 | 177,578 | 185,341 | 149,524 | 13,749 | 13,142 | - | - | - | - | 265,246 | 274,572 | 314,867 | 250,669 | 268,747 | 128,035 | 27,270 | 28,178 | |
| Balance sheet: equity and liabilities | |||||||||||||||||||||
10/49 |
4.6m | 4.3m | 4.3m | 4.0m | 3.8m | 3.6m | 3.7m | 4.3m | 3.9m | 3.3m | 2.8m | 2.7m | 2.7m | 2.4m | 2.5m | 2.5m | 2.5m | 1.8m | 1.4m | 1.3m | |
10/15 |
3.6m | 3.8m | 3.5m | 3.4m | 3.1m | 2.9m | 2.6m | 4.1m | 3.5m | 3.0m | 2.6m | 2.2m | 1.9m | 2.4m | 2.2m | 2.0m | 1.8m | 1.7m | 1.4m | 1.2m | |
10/11 |
20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 2.0m | 2.0m | 2.0m | 2.0m | 2.0m | 2.0m | 18,550 | 18,550 | 18,550 | 18,550 | 18,550 | 18,550 | 18,550 | |
100 |
- | - | - | - | - | - | 20,000 | 2.0m | 2.0m | 2.0m | 2.0m | 2.0m | 2.0m | 18,550 | 18,550 | 18,550 | 18,550 | 18,550 | 18,550 | 18,550 | |
13 |
3.6m | 3.7m | 3.4m | 3.3m | 3.0m | 2.8m | 2.6m | 2.1m | 1.4m | 992,728 | 491,130 | 31,271 | 1,855 | 2.4m | 2.2m | 2.0m | 1.8m | 1.6m | 1.4m | 1.2m | |
130/1 |
196,942 | 196,942 | 196,942 | 198,797 | 198,797 | 198,797 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
130 |
- | - | - | - | - | - | 198,797 | 198,797 | 198,797 | 198,797 | 198,797 | 31,271 | 1,855 | 1,855 | 1,855 | 1,855 | 1,855 | 1,855 | 1,855 | 1,855 | |
1311 |
196,942 | 196,942 | 196,942 | 198,797 | 198,797 | 198,797 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
133 |
3.4m | 3.5m | 3.2m | 3.1m | 2.8m | 2.6m | 2.4m | 1.9m | 1.2m | 793,931 | 292,333 | - | - | 2.4m | 2.2m | 2.0m | 1.8m | 1.6m | 1.4m | 1.2m | |
14 |
43,941 | 43,941 | 43,941 | 43,941 | 43,941 | 43,941 | 43,941 | 43,941 | 43,941 | 24,418 | 88,020 | 134,681 | -39,865 | 5,025 | 3,243 | 2,810 | 4,828 | 5,326 | 3,911 | 5,490 | |
17/49 |
913,688 | 558,067 | 823,065 | 617,052 | 783,049 | 762,005 | 1.1m | 180,298 | 455,566 | 329,876 | 258,240 | 533,391 | 740,082 | 52,086 | 300,002 | 417,036 | 662,576 | 156,384 | 30,858 | 26,957 | |
17 |
- | - | - | - | - | - | 1.1m | - | - | - | - | 229,997 | 262,255 | - | - | - | - | - | - | - | |
170/4 |
- | - | - | - | - | - | 1.1m | - | - | - | - | 229,997 | 262,255 | - | - | - | - | - | - | - | |
42/48 |
913,688 | 558,067 | 823,065 | 610,591 | 775,967 | 762,005 | 1,058 | 180,298 | 455,566 | 329,876 | 258,240 | 303,394 | 477,827 | 30,073 | 289,861 | 417,036 | 659,267 | 22,304 | 20,273 | 11,556 | |
42 |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 350,000 | - | - | - | |
43 |
- | - | - | - | - | - | - | 255 | 316,543 | 70,975 | 45,607 | 300,000 | - | 4,581 | 265,000 | 400,000 | - | - | - | - | |
430/8 |
- | - | - | - | - | - | - | - | 109,566 | 70,799 | - | 300,000 | - | 4,581 | 265,000 | 400,000 | - | - | - | - | |
439 |
- | - | - | - | - | - | - | 255 | 206,977 | 176 | 45,607 | - | - | - | - | - | - | - | - | - | |
44 |
32,001 | 44,816 | 42,035 | 92,084 | 32,555 | 94,007 | 1,058 | 1,228 | 12,960 | 5,864 | 1,580 | 453 | 477,827 | - | - | - | 279,566 | - | - | - | |
440/4 |
32,001 | 44,816 | 42,035 | 92,084 | 32,555 | 94,007 | 1,058 | 1,228 | 12,960 | 5,864 | 1,580 | 453 | 477,827 | - | - | - | 279,566 | - | - | - | |
45 |
168,663 | 88,560 | 125,160 | 112,861 | 27,364 | 29,153 | - | 178,815 | 126,063 | 253,037 | 211,053 | 2,941 | - | - | 24,861 | 17,036 | - | - | - | 11,556 | |
450/3 |
168,663 | 88,560 | 122,660 | 112,861 | 27,364 | 29,153 | - | 178,815 | 126,063 | 253,037 | 211,053 | 2,941 | - | - | 24,861 | 17,036 | - | - | - | 11,556 | |
454/9 |
- | 0 | 2,500 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
47/48 |
713,024 | 424,690 | 655,869 | 405,646 | 716,047 | 638,844 | - | - | - | - | - | - | - | 25,492 | - | - | 29,700 | 22,304 | 20,273 | - | |
492/3 |
- | - | 0 | 6,461 | 7,082 | - | - | - | - | - | - | - | - | 22,012 | 10,140 | - | 3,309 | 134,079 | 10,585 | 15,401 | |
| Income statement | |||||||||||||||||||||
70 |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 590,628 | |
76A |
- | - | - | 0 | 330,483 | 476,732 | - | 141,380 | - | - | - | - | - | - | - | - | - | - | 5,000 | - | |
9900 |
781,629 | 986,977 | 1.1m | 1.1m | 958,773 | 1.1m | 721,674 | 968,998 | 779,891 | 793,723 | 676,518 | 305,119 | -50,683 | 306,925 | 332,039 | 400,522 | 291,733 | 395,848 | 314,396 | 403,621 | |
60/61 |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 187,554 | |
62 |
- | - | 324 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
630 |
21,906 | 21,638 | 21,798 | 20,675 | 40,122 | 19,757 | 36,460 | 45,130 | 51,103 | 65,169 | 68,857 | 71,450 | 64,921 | 62,998 | 86,122 | 74,489 | 60,498 | 75,486 | 77,657 | 33,144 | |
640/8 |
1,316 | 1,514 | 1,161 | 2,377 | 128,983 | 6,719 | 7,341 | 9,678 | 6,421 | 6,744 | 6,852 | 5,510 | 5,878 | 5,143 | 4,117 | 2,570 | 9,270 | 2,704 | 2,527 | 2,365 | |
66A |
- | - | - | - | 0 | 54 | - | - | - | - | 46,003 | - | - | - | - | - | - | - | - | - | |
9901 |
758,407 | 963,825 | 1.1m | 1.1m | 789,668 | 1.1m | 677,873 | 914,190 | 722,367 | 721,810 | 600,809 | 228,159 | -121,482 | 238,783 | 241,800 | 323,464 | 221,965 | 317,658 | 234,212 | 368,112 | |
75/76B |
176,113 | 127,808 | 71,923 | 24,910 | 19,125 | 18,919 | 18,722 | 159,743 | 15,070 | 1,613 | 1,461 | 2,436 | 1,357 | 15,223 | 14,831 | 14,448 | 16,646 | 23,217 | 26,103 | 23,128 | |
75 |
176,113 | 127,808 | 71,923 | 24,910 | 19,125 | 18,919 | 18,722 | 18,363 | 15,070 | 1,613 | 1,461 | 2,436 | 1,357 | 15,223 | 14,831 | 14,448 | 16,646 | 23,217 | 26,103 | 23,128 | |
76B |
- | - | - | - | - | - | - | 141,380 | - | - | - | - | - | - | - | - | - | - | - | - | |
65/66B |
305 | 3,219 | 2,004 | 17,913 | 10,901 | 16,695 | 574 | 2,671 | 7,842 | 1,025 | 6,796 | 224 | 1,467 | 4,841 | 8,909 | 7,871 | 6,115 | 127 | 867 | 2,236 | |
65 |
305 | 3,219 | 2,004 | 17,913 | 10,901 | 16,695 | 574 | 2,671 | 7,842 | 1,025 | 6,796 | 224 | 1,467 | 4,841 | 8,909 | 7,871 | 6,115 | 127 | 867 | 2,236 | |
9903 |
934,215 | 1.1m | 1.1m | 1.1m | 797,892 | 1.1m | 696,021 | 1.1m | 729,595 | 722,398 | 549,471 | 230,371 | -121,592 | 249,165 | 247,721 | 330,040 | 232,495 | 340,749 | 264,448 | 389,004 | |
67/77 |
303,702 | 351,991 | 376,677 | 353,058 | 203,650 | 346,373 | 248,979 | 380,873 | 283,076 | 284,402 | 136,273 | 26,409 | 95,055 | 72,383 | 82,289 | 112,058 | 57,993 | 104,334 | 81,026 | 127,335 | |
9904 |
630,513 | 736,423 | 763,465 | 742,332 | 594,242 | 750,551 | 447,042 | 690,389 | 446,519 | 437,996 | 413,198 | 203,962 | -216,647 | 176,782 | 165,433 | 217,982 | 174,502 | 236,415 | 183,422 | 261,669 | |
789 |
- | - | - | - | - | - | - | - | - | - | - | - | 2.4m | - | - | - | - | - | - | - | |
689 |
- | - | - | - | - | - | - | - | 426,996 | 88,020 | 145,334 | - | - | - | - | - | - | - | - | - | |
9905 |
630,513 | 736,423 | 763,465 | 742,332 | 594,242 | 750,551 | 447,042 | 690,389 | 19,523 | 349,976 | 267,864 | 203,962 | 2.1m | 176,782 | 165,433 | 217,982 | 174,502 | 236,415 | 183,422 | 261,669 | |
| Appropriation of the result | |||||||||||||||||||||
9906 |
674,454 | 780,363 | 807,406 | 786,273 | 638,183 | 794,492 | 490,983 | 734,330 | 43,941 | 437,996 | 402,545 | 164,097 | 2.1m | 180,025 | 168,243 | 222,810 | 179,828 | 240,326 | 188,911 | 265,490 | |
14P |
43,941 | 43,941 | 43,941 | 43,941 | 43,941 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
791/2 |
750,551 | 447,043 | 690,389 | 426,996 | 413,578 | 489,275 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
691/2 |
630,513 | 736,423 | 763,465 | 742,332 | 594,242 | 750,551 | 447,042 | 690,389 | - | 413,578 | 314,525 | 29,416 | - | 175,000 | 165,000 | 220,000 | 175,000 | 235,000 | 185,000 | 260,000 | |
6920 |
- | - | - | - | - | - | - | - | - | - | 22,192 | 29,416 | - | - | - | - | - | - | - | - | |
6921 |
630,513 | 736,423 | 763,465 | 742,332 | 594,242 | 750,551 | 447,042 | 690,389 | - | 413,578 | 292,333 | - | - | 175,000 | 165,000 | 220,000 | 175,000 | 235,000 | 185,000 | 260,000 | |
694/7 |
750,551 | 447,043 | 690,389 | 426,996 | 413,578 | 489,275 | - | - | - | - | - | - | 2.2m | - | - | - | - | - | - | - | |
694 |
750,551 | 447,043 | 690,389 | 426,996 | 413,578 | 489,275 | - | - | - | - | - | - | 2.2m | - | - | - | - | - | - | - | |
| Social balance sheet | |||||||||||||||||||||
9087 |
0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| Document | |||||||||||||||||||||
The accounts for 15 older financial years (1991-2005) were filed as documents without figures as data, scans for example.
The notes to these accounts have 17 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2025 (PDF), filed on 22-04-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 22-04-2026 | 2026-00084906 | |
| 31-12-2024 | abbreviated format | 10-06-2025 | 2025-00130947 | |
| 31-12-2023 | abbreviated format | 26-06-2024 | 2024-00163273 | |
| 31-12-2022 | abbreviated format | 17-07-2023 | 2023-00247153 | |
| 31-12-2021 | abbreviated format | 29-08-2022 | 2022-20345104 | |
| 31-12-2020 | abbreviated format | 31-08-2021 | 2021-64100419 | |
| 31-12-2019 | abbreviated format | 12-08-2020 | 2020-40400173 | |
| 31-12-2018 | abbreviated format | 21-08-2019 | 2019-47900229 | |
| 31-12-2017 | abbreviated format | 30-08-2018 | 2018-53300052 | |
| 31-12-2016 | abbreviated format | 11-08-2017 | 2017-42600099 | |
| 31-12-2015 | abbreviated format | 31-08-2016 | 2016-51400432 | |
| 31-12-2014 | abbreviated format | 31-08-2015 | 2015-50500467 | |
| 31-12-2013 | abbreviated format | 29-09-2014 | 2014-60200288 | |
| 31-12-2012 | abbreviated format | 30-11-2013 | 2013-67800101 | |
| 31-12-2011 | abbreviated format | 31-10-2012 | 2012-63300498 | |
| 31-12-2010 | abbreviated format | 31-12-2011 | 2011-66100023 | |
| 31-12-2009 | abbreviated format | 15-11-2010 | 2010-60700127 | |
| 31-12-2008 | abbreviated format | 31-10-2009 | 2009-84700189 | |
| 31-12-2007 | abbreviated format | 30-12-2008 | 2008-87900024 | |
| 31-12-2006 | abbreviated format | 28-08-2007 | 2007-63600019 | |
| 31-12-2005 | abbreviated format | 30-08-2006 | 2006-73502705 | |
| 31-12-2004 | abbreviated format | 21-09-2005 | 2005-69401718 | |
| 31-12-2003 | abbreviated format | 05-11-2004 | 2004-78002655 | |
| 31-12-2002 | abbreviated format | 31-07-2003 | 2003-56201968 | |
| 31-12-2001 | abbreviated format | 17-09-2002 | 2002-56300336 | |
| 31-12-2000 | abbreviated format | 27-12-2001 | 2001-78403222 | |
| 31-12-1999 | abbreviated format | 20-10-2000 | 2000-66703000 | |
| 31-12-1998 | abbreviated format | 22-12-1999 | 1999-64200385 | |
| 31-12-1997 | abbreviated format | 07-10-1998 | 1998-51701165 | |
| 31-12-1996 | abbreviated format | 28-08-1997 | 1997-40103107 | |
| 31-12-1995 | abbreviated format | 11-09-1996 | 1996-43302640 | |
| 31-12-1994 | abbreviated format | 07-08-1995 | 1995-44503762 | |
| 31-12-1993 | abbreviated format | 27-03-1995 | 1995-04404339 | |
| 31-12-1992 | abbreviated format | 09-07-1993 | 1993-25500328 | |
| 31-12-1991 | abbreviated format | 23-09-1992 | 1992-32604618 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 780,313 | 985,463 | 1.1m | 1.1m | 829,790 | 1.1m | 714,333 | 959,320 | 773,470 | 786,979 | 669,666 | 299,609 | -56,561 | 301,782 | 327,922 | 397,952 | 282,463 | 393,144 | 311,869 | 401,256 | ||
| 652,419 | 758,061 | 785,262 | 763,007 | 634,364 | 770,308 | 483,502 | 735,519 | 497,622 | 503,165 | 482,055 | 275,412 | -151,726 | 239,781 | 251,555 | 292,471 | 234,999 | 311,901 | 261,078 | 294,813 | ||
| 1,405 | 3,347 | 6,961 | 4,142 | 9,051 | 96,452 | 0 | 451 | 4,335 | 2,353 | 4,060 | 35,219 | 54,748 | 41,377 | 62,961 | 23,282 | 1.0m | 75,462 | 362,431 | 33,337 | ||
| 23,313 | 8,526 | -1.2m | 815,637 | 97,651 | 117,020 | -393,574 | 187,654 | 1,651 | -646,519 | 758,327 | 119,164 | 287,447 | -1,798 | -26,617 | 18,320 | -503,501 | 240,562 | -109,275 | - | ||
| 3.6m | 3.7m | 3.4m | 3.3m | 3.0m | 1.8m | 2.6m | 3.0m | 2.2m | 1.7m | 1.2m | 949,698 | 741,763 | 843,069 | 632,793 | 434,058 | 168,179 | 1.1m | 758,443 | 864,611 | ||
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 62.3% | ||
| 80.0% | 87.1% | 80.8% | 84.6% | 79.6% | 79.1% | 70.4% | 95.8% | 88.3% | 90.1% | 90.9% | 80.2% | 72.5% | 97.9% | 88.0% | 83.0% | 73.4% | 91.3% | 97.9% | 97.9% | ||
| 4.97 | 7.68 | 5.16 | 6.47 | 4.85 | 3.32 | - | 17.42 | 5.81 | 6.15 | 5.64 | 4.13 | 2.55 | 29.03 | 3.18 | 2.04 | 1.26 | 51.14 | 38.41 | 75.82 | ||
| 0.25 | 0.15 | 0.24 | 0.18 | 0.26 | 0.26 | 0.42 | 0.04 | 0.13 | 0.11 | 0.10 | 0.25 | 0.38 | 0.02 | 0.14 | 0.20 | 0.36 | 0.09 | 0.02 | 0.02 | ||
| 17.3% | 19.6% | 22.0% | 21.8% | 19.4% | 26.0% | 17.1% | 16.7% | 12.9% | 14.6% | 16.1% | 9.5% | -11.1% | 7.4% | 7.5% | 10.7% | 9.6% | 14.3% | 13.0% | 21.3% | ||
| 13.8% | 17.0% | 17.8% | 18.5% | 15.5% | 20.6% | 12.0% | 16.0% | 11.4% | 13.1% | 14.6% | 7.6% | -8.1% | 7.3% | 6.6% | 8.9% | 7.0% | 13.1% | 12.7% | 20.8% | ||
| over 100 | over 100 | over 100 | 61.91 | 76.12 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17 days |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €1,405 | €3,347 | €1,385 | €4,142 | €9,051 |
| Financial fixed assets | €0 | - | €5,576 | - | - |
| €21,906 | €21,638 | €21,798 | €20,675 | €40,122 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on A&E
The operating result for 2025 is 21% lower than in 2024 and the lowest since 2019. It is the third fall in a row.
Debt's share of the balance-sheet total rises from 12.9% to 20.0%. Equity is lower and debt is higher.
Board & ownership
Board
2 directors, last change in 2020Director
since 06-11-2003
listed in the 2025 annual accounts, filed on 22-04-2026
Director
since 25-03-2019
term without a fixed end
listed in the 2025 annual accounts, filed on 22-04-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- The sole directordeed of 08-04-2020
Mandates through the years
3 names, the dashed line is todayBoardEarliermandate already running before its first mention
Mandates as a list
- HEYLEN René Joseph Jean Maria
- Director, from 06-11-2003 to date
- HEYLEN Micheline
- Director, from 25-03-2019 to date
- HEYLEN Line
- Director, until 08-04-2020
Control
Shareholder
HEYLEN René
This company
A&E
Equity €3.6m
Profit €630,513 in 2025
Capital
- Contribution
- €20,000
- Shares
- 172
- Contribution per share
- €116
- Equity per share
- €21,186 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 08-04-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- Term of at most 20 years
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June
Shareholders
Stated in the deed
deed of 04-01-2022 ↗
- HEYLEN René all shares
Stated in the deed
deed of 08-04-2020 ↗
- HEYLEN René Joseph Jean Maria all shares
Network & group
No group
A&E has no parent and no holdings in its annual accounts.
Connections & network
4 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
Mithridate
Shared director · deed of 06-06-2023
Founded in 2023 · total assets €164,214 (2025) · negative equity
→
Dr. M. Heylen
via HEYLEN Micheline · Director (not named in the articles) · deed of 21-09-2020
Founded in 2020 · total assets €159,749 (2024) · accounts filed late
→
→
→
Timeline
Timeline
48 events since 1990Board
Filings
Financial
Establishments
Other
19901995200020052010201520202025
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed PDFabbreviated format · 100 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0440535396
Annual accounts 2024 filed PDFabbreviated format · 51 days before the deadline
2024
Annual accounts 2023 filed PDFabbreviated format · 35 days before the deadline
2023
Highest result from 2006 to 2025 net €763,465 ▲2.8% The net result of €763,465 is the highest of those years.
Annual accounts 2022 filed PDFabbreviated format · 14 days before the deadline
Purpose change“Het bij wijze van inschrijving,inbreng,fusie samenwerking,financiële tussenkomt of anderszins verwerven van…” (deed in Dutch) · General meeting of 13-04-20233 points ▸
- General meeting, 13-04-2023
- Purpose change, “Het bij wijze van inschrijving,inbreng,fusie samenwerking,financiële tussenkomt of anderszins verwerven van een belang of deelneming in alle bestaande of nog op…” (deed in Dutch)
- Amendment of the articles, article 3
- The deed holds 2 more points.
2022
Annual accounts 2021 filed PDFabbreviated format · 29 days late
HEYLEN René holds all the sharesDirector in office: HEYLEN René1 point ▸
- HEYLEN René holds all the shares
- The deed holds 3 more points.
2021
Annual accounts 2020 filed PDFabbreviated format · 31 days late
2020
Annual accounts 2019 filed PDFabbreviated format · 12 days late
1 director resigning, 2 reappointmentsResignation: HEYLEN Line · Reappointments: HEYLEN René Joseph Jean Maria and HEYLEN Micheline · HEYLEN René Joseph Jean Maria holds all the shares · General meeting of 27-03-20207 points ▸
- General meeting, 27-03-2020
- HEYLEN René Joseph Jean Maria holds all the shares
- Director resignation, HEYLEN Line
- Director discharge, HEYLEN Line
- Director reappointment, HEYLEN René Joseph Jean Maria
- Director reappointment, HEYLEN Micheline
- 172 shares
- The deed holds 5 more points.
2019
Liquidity more than 139 times current ratio 2434.60 The current ratio rises from 17.42 to 2434.60. Short-term debt falls from €180,298 to €1,058.
Annual accounts 2018 filed PDFabbreviated format · 21 days late
2018
Liquidity more than doubled current ratio 17.42 The current ratio rises from 5.81 to 17.42. Short-term debt falls from €455,566 to €180,298.
Annual accounts 2017 filed PDFabbreviated format · 30 days late
2017
Annual accounts 2016 filed PDFabbreviated format · 11 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 31 days late
2015
Annual accounts 2014 filed PDFabbreviated format · 31 days late
2014
Back to profit net €203,962 The net result is €203,962, after one loss-making year.
Annual accounts 2013 filed PDFabbreviated format · 60 days late
2013
Weakest financial year net -€216,647 The net result drops to -€216,647, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2012 filed PDFabbreviated format · 122 days late
2012
Liquidity more than 9 times current ratio 29.03 The current ratio rises from 3.18 to 29.03. Short-term debt falls from €289,861 to €30,073.
Annual accounts 2011 filed PDFabbreviated format · 92 days late
2011
Annual accounts 2010 filed PDFabbreviated format · 153 days late
2010
Equity above €2m equity €2.0m ▲11.9% With a profit in every financial year since 2006, equity grows to €2.0m.
Annual accounts 2009 filed PDFabbreviated format · 107 days late
2009
Annual accounts 2008 filed PDFabbreviated format · 92 days late
2008
Annual accounts 2007 filed PDFabbreviated format · 152 days late
2007
Annual accounts 2006 filed PDFabbreviated format · 28 days late
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2002
Annual accounts 2001 filed PDFabbreviated format
2001
Annual accounts 2000 filed PDFabbreviated format
2000
Annual accounts 1999 filed PDFabbreviated format
1999
Annual accounts 1998 filed PDFabbreviated format
1998
Annual accounts 1997 filed PDFabbreviated format
1997
Annual accounts 1996 filed PDFabbreviated format
1996
Annual accounts 1995 filed PDFabbreviated format
1995
Annual accounts 1994 filed PDFabbreviated format
Annual accounts 1993 filed PDFabbreviated format
1993
Annual accounts 1992 filed PDFabbreviated format
1992
Annual accounts 1991 filed PDFabbreviated format
1990
Incorporation published on 01-05-1990
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 0440.535.396
- VAT number
- BE 0440.535.396
- Peppol ID
- 0208:0440535396
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 03-04-1990
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of Junedeed of 08-04-2020 (in Dutch)
- Peppol
- Reachable since 29-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- A&E in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 08-04-2020 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Vlaams Gewest”deed of 08-04-2020 (in Dutch)
Activities
NACEBEL 202586220
Specialist medical practice main activity
Codes under NACEBEL 2008
86220
Human health activities main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “In binnen- en buitenland het uitoefenen,organiseren,bevorderen en structureren van alle beroepsactiviteiten van de arts-aandeelhouder of…”deed of 21-04-2023 (in Dutch)
17 activities
- In binnen- en buitenland het uitoefenen,organiseren,bevorderen en structureren van alle beroepsactiviteiten van de arts-aandeelhouder of artsen-aandeelhouders op de gebieden van de anesthesie (inclusief pijnbehandeling) en reanimatie (intensieve geneeskunde,urgentiegeneeskunde,medische reisbijstand en binnen- en buitenlandse evacuatie van patiënten),de gerechtelijke geneeskunde en de evaluatie menselijke schade,dit alles rekening houdend met de regelen van de medische plichtenleer qua uitoefening van de geneeskunde
- De geneeskunde zal enkel door de arts-aandeelhouder of artsen-aandeelhouders uitgeoefend worden
- Het uitvoeren van medische expertises
- Het zetelen in commissies en organen waar het wettelijk diploma van arts of een bijzonder beroepstitel voor vereist is
- De vennootschap ontvangt rechtstreeks alle verschuldigde honoraria en int voor eigen rekening
- Het ter beschikking stellen van nodige middelen voor de arts-aandeelhouders
- Het inrichten van algemene diensten en medisch secretariaat in het bijzonder,die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten
- Het verwerven,huren en/of leasen van alle medische apparatuur en begeleidende accommodaties,inclusief gebouwen en transportmiddelen,kortom van een volledige materiele infrastructuur voor de praktijk van de artsen-aandeelhouders
- Het scheppen van de mogelijkheden om de arts-aandeelhouder toe te laten zich verder te bekwamen in voormelde disciplines,dit teneinde een hoogstaande praktijkuitoefening mogelijk te maken
- De organisatie van seminaries,colloquia,cursussen,studiereizen en lessen in verband met de beroepsactiviteiten
- De vennootschap kan bovendien alle werkzaamheden en rechtshandelingen verrichten die van aard zijn om rechtstreeks de verwezenlijking van haar doel te bevorderen
- De vennootschap kan zonder afbreuk te doen aan de medische plichtenleer onder het normale beheer als goede huisvader een bestemming geven aan haar gereserveerde winsten
- Het bij wijze van inschrijving,inbreng,fusie samenwerking,financiële tussenkomt of anderszins verwerven van een belang of deelneming in alle bestaande of nog op te richten vennootschappen,ondernemingen,bedrijvigheden,instellingen of verenigingen zonder onderscheid in België of in het buitenland
- Het beheren,valoriseren en te gelde malen van deze belangen of deelnemingen of rechten en het onderzoeken van investerings- en desinvesteringsopportuniteiten,alsook het rechtstreeks of onrechtstreeks deelnemen aan het bestuur,de directie,de controle en vereffening van de vennootschappen,ondernemingen,bedrijvigheden,instellingen en verenigingen waarin de vennootschap een belang of deelneming of enig ander recht heeft
- Het verlenen van alle advies en bijstand op alle mogelijke vlakken van de bedrijfsvoering aan het bestuur en de directie van de vennootschappen,ondernemingen,bedrijvigheden,instellingen en verenigingen waarin zij een belang of deelneming of enig ander geheel of gedeeltelijk,rechtstreeks of onrechtstreeks behoren tot de activiteiten van een moedervennootschap
- Het aankopen,ruilen of anderszins verwerven,het verkopen,huren,verhuren,verkavelen,doen bouwen,doen verbouwen,doen bebouwen,van alle al dan niet bebouwde onroerende goederen,of rechten op onroerende goederen,in België en in het buitenland,alsmede het verrichten van alle handelingen die nodig,nuttig of dienstig zijn voor het beheren en uitbaten van een onroerend patrimonium van de vennootschap
- Het aankopen,verkopen,overdragen,beheren,te gelde maken en valoriseren,van alle roerende en rechten,en het stellen van alle handelingen of daden die nodig of nuttig zijn voor het beheer van dit roerend patrimonium van de vennootschap
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Weg naar As 155 registered office 3600 Genk | 18-01-2003 | 2.350.685.528 |
Buildings and parcels at the address
- Ground area
- 2,826 m²
- Buildings
- 156 m²
- Volume, LiDAR
- 999 m³
- Tallest building
- 9.5 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 71016I1410/00Z047 | 2,826 m² | 1 · 156 m² | 9.5 m · 2 |